Peer Review History
Original SubmissionJuly 14, 2020 |
---|
PONE-D-20-21800 Knowledge of mother-to-child transmission of HIV and uptake of HIV testing during pregnancy: findings from 14 sub-Saharan African countries PLOS ONE Dear Dr. Ajayi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Many thanks for your submission which highlights important discrepancies in and consequences of vertical transmission of HIV policies across the region. Both reviewers have highlighted concerns regarding the presentation of the methodology and the conclusions drawn. The premise that there is a straight-forward causal relationship between knowledge and testing needs to be examined in more detail to account for study design, confounding and colinearity. Here regional PMTCT policy and practice are important: education and counselling as part of PMTCT, opt-out testing versus opt-in etc. Similarly,as noted in the discussion, ANC attendance is vital. Please check the formatting of the tables including denominators (e.g. Table 2), units (e.g. Table 3) and general formatting (e.g. Table 5) where appropriate. Please note, one set of comments is included as an attachment. Please submit your revised manuscript by Oct 12 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Emma K. Kalk Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information about the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) a description of any inclusion/exclusion criteria that were applied to participant inclusion in the analysis (specifying what illnesses' were considered), b) a table of relevant demographic details. 3. Please include a separate caption for each figure in your manuscript. 4. We note you have included tables to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables 1 and 2 in your text; if accepted, production will need this reference to link the reader to each Table. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Knowledge of mother-to-child transmission of HIV and uptake of HIV testing during pregnancy: findings from 14 sub-Saharan African countries Awopegba OE, et al Comments Abstract Line 49-51:‘The odds of prenatal care HIV testing was significantly higher [21.21, CI=20.03,22.46] in countries where most women knew of MTCT compared to countries where most women did not know of MTCT routes of transmission.’ Comment While from the these results are true based on the data used, but there some confounding factors, for example in Uganda it is kind of a must for every pregnant mother who attends ANC to test for HIV, rather than a voluntary choice of the mother. So these health systems differences across the countries have to be taken into account, before we conclude that the testing rates of HIV during prenatal are due to the level of knowledge. Like I have mentioned in these countries like Rwanda and Uganda, HIV testing is ‘mandatory’ during ANC, and the mothers are also given health education. One would love to know the health systems dynamics for PMTCT in West Africa, where testing and knowledge are low, so as to put these findings into context. Line 53-56: The conclusion of ‘educating women of the risk of MTCT could be an important strategy for increasing HIV testing uptake, especially in West and Central Africa, where the rate of testing during pregnancy remains low, and the rate of MTCT remain high, is not the only solution, when other factors are not addressed, because knowledge alone without addressing health systems barriers is not enough. Line 77-78.’ Global north countries with a universal prenatal care HIV screening among pregnant women have nearly eliminated MTCT of HIV.’ Need to provide the source of this information. But also this statement underscores the importance of having the prenatal care HIV screening among pregnant women. It is not clear if these services are available in West Africa, where MTCT HIV rates are high and testing is low. Line 89-91: The authors emphasize the importance of knowledge in facilitation HIV testing among prenatal mothers, but literature has shown that knowledge alone is not enough. ‘Knowledge of MTCT is considered essential to facilitate HIV testing since women with knowledge of HIV transmission have a better understanding and appreciation of the need for HIV testing and the perceived benefit of testing not only for them but also for their infant 17’. Line 92-107: The authors are using The Health Belief Model (HBM) with the premise that knowledge is enough for mothers to test. I feel they should have used more comprehensive models of behaviour change e.g. the approach the Capability, Opportunity and Motivation Model of Behaviour (COM-B) model (Michie S 2011), see figure below. According to the model, behaviour is a product of three necessary conditions; capability, opportunity, and motivation. Capability can be psychological (knowledge) or physical (skills), opportunity can be social (societal influences) or physical (environmental resources) while motivation can be automatic (emotion) or reflective (beliefs, intentions). Such model like COM-B gives a comprehensive analysis of the issues that affect prenatal HIV testing. Therefore, the current analysis gives a narrow picture. Figure 1. COM-B Model Michie S 2011. Therefore, the authors need to recognize the limitations of their theoretical approach, is not comprehensive enough in exploring the factors that affect prenatal HIV testing. But also the secondary data limitations, not able to have collected other data such as health systems factors e.g availability of testing services, how testing is done, etc. Line 210-2013: Table 3. The authors don’t give the reference point and also should provide the confidence intervals. Line 2017-2025: In all countries, women who had moderate to high knowledge of MTCT had higher odds of HIV testing uptake during pregnancy compared with women who had low MTCT 219 knowledge. In Model 2, we added sociodemographic factors, media exposure, and health insurance as covariates. After adjusting for covariates, the magnitude and direction of effect persisted, indicating a strong and robust effect of MTCT knowledge on uptake of HIV testing during pregnancy. The odds of prenatal HIV testing uptake was higher among women with high MTCT 223 knowledge, especially in Chad (AOR: 38.30; 95% CI: 26.23, 55.93), Benin (AOR: 40.65; 95% CI: 224 31.95, 51.72), Angola (AOR:8.14; 95% CI:6.77, 9.78), Burundi (AOR: 53.37; 95% CI: 36.00, 225 79.11), and Zimbabwe (AOR: 19.1; 95% CI: 10.4, 35.0). Comment: Though this data analysis is correct, it has limitation of health systems issues on the ground. Table 4; Also does not provide reference points/measurements. Comment: It would also be important for this study to give us a clue on the prevalence of couple testing, given that the pregnant mother testing alone without the partner leaves a gap in terms of achieving the PMTCT targets. The authors should acknowledge the limitations of this secondary data analysis. Reviewer #2: Review attached separately . ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
PONE-D-20-21800R1 Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries PLOS ONE Dear Dr. Ajayi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you submitting your revised manuscript. The manuscript has benefitted from the change in focus and the additional analyses included as Supplementary Data. However, some important issues raised by the initial reviewers have only been addressed in part. I have summarized the outstanding issues below. Please submit your revised manuscript by Nov 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Emma K. Kalk Academic Editor PLOS ONE Additional Editor Comments (if provided): PONE-D-20-21800R1 Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries The authors have submitted a revised manuscript the focus of which has been broadened to include multiple factors associated with antenatal HIV testing uptake in sub-Saharan Africa. This widening of scope addresses some of the main concerns with the initial report in that 1) the study design (cross-sectional surveys) did not support a causal relationship between HIV-knowledge and test uptake; 2) confounding and collinearity, particularly related to country-specific PMTCT policies which may include mandatory/opt-out ANC education and testing, and country-specific uptake of ANC services in general. However, some of the issues raised have not been completely addressed. General The Title, Abstract and Discussion have been revised to reflect the change in focus i.e. “coverage of HIV testing during pregnancy and also examine the factors associated with uptake.” The Results section remains focused on Knowledge. As noted in previous reviewer comments: attendance of ANC=pretest counselling=knowledge. Attendance of ANC=test. Do you have any data on ANC uptake? Please apply consistency with respect to numbers i.e. numerals or words. Specific Line 84-84. ANC testing is standard of care in Botswana and South Africa (every 3 months in the latter) with an opt-out policy. HIV education is part of the testing process. line 108. Add: “According to the COM-B model….” You have described the summary of the COM-B model suggested by the reviewer. Please could you apply this to the analysis. Line 134. You appropriately use the weighted datasets from the DHS surveys. As noted before, please provide a brief description of what this means in the text of Methods. Line 143. Why did you select “knowledge” as the main explanatory variable of interest? As noted, this is likely colinear with local PMTCT policy and ANC attendance itself, both of which may be more relevant. Perhaps “knowledge” could be included as one of several variables. You should also note that COUNTRY was a variable included in your models. Line 158. The Media Exposure classification is still unclear. You present 2 classifications: low = 0; moderate =1-3 or 1-4; high=4-6 or 5-9. Do the latter apply to Zambia only? If it isn’t possible to apply a single classification, please be explicit as to which system is applied to which country. Line 169. Detail on weightings as noted above. You only need provide this once. FIGURES: Has Figure 1 been deleted? There is no longer a legend. Please relabel all the Figures starting at 1 in the text and Figure legends. Table 2. What is the Total column? It looks like the total number of women included i.e. your denominator? The cause of confusion is use of the comma which you haven’t used in the frequency columns. Please be consistent with the numbers. Line 220. Typo – “never” is floating.. “never-married”? Proportion is singular so “proportion …. was higher…” Line 224. Sentence incomplete. Line 236. “To examine the factors associated with uptake of HIV testing during pregnancy, we fitted two models and presented the results in (Table 4).” Line 245 – 246. Please could you include COUNTRY as a variable in both models in Table 4. ANC uptake and PMTCT policy, which are captured in the COUNTRY variable, are key factors in ANC testing uptake. I note stratified results are presented in Supplementary tables. Perhaps mention that you have looked at ANC uptake (Supplementary 7). Is there a reason you couldn’t use this as a variable in the models? Line 301. Delete “also” Lines 320-324. The focus of the manuscript has broadened. I feel that emphasis on Knowledge limits the discussion. As noted, Knowledge is colinear with many other variables which may be more important. The study proposition is no longer defining a causal relationship between knowledge and testing (this is not possible with the study design). Lines 330-332 are more important. Line 332. The COM-B theoretical model (mentioned in the Introduction) could be very useful here as it would address some of the issues with confounding. It would be useful to discuss it’s application to your analysis here, as you do with the HBM model. Line 335. Does media exposure differ by urban-rural area of SES status? [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries PONE-D-20-21800R2 Dear Dr. Ajayi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Emma K. Kalk Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-20-21800R2 Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries Dear Dr. Ajayi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Emma K. Kalk Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .